Cancer And Metastasis Reviews SCIE

国际简称：CANCER METAST REV 参考译名：癌症和转移评论

主要研究方向：医学-肿瘤学非预警期刊审稿周期：较慢,6-12周

《癌症和转移评论》(Cancer And Metastasis Reviews)是一本由Springer US出版的以医学-肿瘤学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

2区中科院分区
Q1 JCR分区
71 年发文量
7.7 IF影响因子
未开放 是否OA
134 H-index
1982 创刊年份
Quarterly 出版周期
English 出版语言

Contemporary biomedical research is on the threshold of an era in which physiological and pathological processes can be analyzed in increasingly precise and mechanistic terms. The transformation of biology from a largely descriptive, phenomenological discipline to one in which the regulatory principles can be understood and manipulated with predictability brings a new dimension to the study of cancer and the search for effective therapeutic modalities for this disease. Cancer and Metastasis Reviews provides a forum for critical review and discussion of these challenging developments.

Each issue of Cancer and Metastasis Reviews is devoted to a particular theme or topic and will contain from five to seven different contributions. In addition, an introductory preface is included from an individual who is distinguished in the field to be covered. The topics and contributors are chosen by the Editor-in-Chief after consultation with various members of the Editorial Advisory Board. Special emphasis is placed on subjects which are of relevance to the molecular and cellular biology of cancer metastasis and tumor progression, as well as to the treatment of metastatic disease. Occasional issues will be devoted to an in-depth clinical and biological analysis of a particular type of cancer.

A major function of the journal is to review some of the more important and interesting recent developments in the biology and treatment of malignant disease, as well as to highlight new and promising directions, be they technological or conceptual. Contributors are encouraged to review their personal work and be speculative.

[ 查看全部 ]

投稿咨询加急咨询

Cancer And Metastasis Reviews期刊信息

ISSN：0167-7659
出版语言：English
是否OA：未开放
E-ISSN：1573-7233
出版地区：UNITED STATES
是否预警：否
出版商：Springer US
出版周期：Quarterly
创刊时间：1982
开源占比：0.3936
Gold OA文章占比：43.10%
OA被引用占比：0.1817...
出版国人文章占比：0.06
出版撤稿占比：0
研究类文章占比：0.00%

Cancer And Metastasis Reviews CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

2.866

1.934

学科类别	分区	排名	百分位
大类：Medicine 小类：Oncology	Q1	29 / 404	92%
大类：Medicine 小类：Cancer Research	Q1	22 / 230	90%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Cancer And Metastasis Reviews中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	是	医学	2区	ONCOLOGY 肿瘤学	2区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	是	医学	2区	ONCOLOGY 肿瘤学	2区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	是	医学	2区	ONCOLOGY 肿瘤学	2区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	是	医学	2区	ONCOLOGY 肿瘤学	2区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	是	医学	2区	ONCOLOGY 肿瘤学	2区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	是	医学	2区	ONCOLOGY 肿瘤学	2区

Cancer And Metastasis Reviews JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q1	37 / 322	88.7%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q1	67 / 322	79.35%

Cancer And Metastasis Reviews历年数据统计

影响因子

中科院分区

Cancer And Metastasis Reviews中国学者发文选摘

1、Colorectal cancer liver metastasis: genomic evolution and crosstalk with the liver microenvironment
Author: Liu, Qiu-Luo; Zhou, Huijie; Zhou, Zong-Guang; Chen, Hai-Ning

Journal: CANCER AND METASTASIS REVIEWS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10555-023-10107-0
2、Circadian disruption: from mouse models to molecular mechanisms and cancer therapeutic targets
Author: Wang, Yu; Guo, Haidong; He, Feng

Journal: CANCER AND METASTASIS REVIEWS. 2023; Vol. 42, Issue 1, pp. 297-322. DOI: 10.1007/s10555-022-10072-0
3、Potential biomarkers for immunotherapy in non-small-cell lung cancer
Author: Wang, Xing; Qiao, Ziyun; Aramini, Beatrice; Lin, Dong; Li, Xiaolong; Fan, Jiang

Journal: CANCER AND METASTASIS REVIEWS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10555-022-10074-y
4、Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers
Author: Wang, Yu; Deng, Baocheng

Journal: CANCER AND METASTASIS REVIEWS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10555-023-10084-4
5、The tumor-nerve circuit in breast cancer
Author: Cui, Qiuxia; Jiang, Dewei; Zhang, Yuanqi; Chen, Ceshi

Journal: CANCER AND METASTASIS REVIEWS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s10555-023-10095-1
6、Stromal cells in tumor microenvironment and breast cancer
Author: Yan Mao, Evan T. Keller, David H. Garfield, Kunwei Shen, Jianhua Wang

Journal: CANCER AND METASTASIS REVIEWS, 2012, Vol.32, 303-315, DOI:10.1007/s10555-012-9415-3
7、The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression
Author: Junli Deng, Li Wang, Hongmin Chen, Lei Li, Yiming Ma, Jie Ni, Yong Li

Journal: CANCER AND METASTASIS REVIEWS, 2013, Vol.32, 535-551, DOI:10.1007/s10555-013-9423-y
8、Central and peripheral nervous systems: master controllers in cancer metastasis
Author: Ming Shi, Dan Liu, Zhengyan Yang, Ning Guo

Journal: CANCER AND METASTASIS REVIEWS, 2013, Vol.32, 603-621, DOI:10.1007/s10555-013-9440-x